EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Altered transcriptomic immune responses of maintenance hemodialysis patients to the COVID-19 mRNA vaccine

Yi-Shin Chang iD, Kai Huang iD, Jessica M Lee iD, Christen L Vagts, Christian Ascoli iD, Md-Ruhul Amin, Mahmood Ghassemi, Claudia M Lora, Russell Edafetanure-Ibeh, Yue Huang, Ruth A Cherian, Nandini Sarup und 13 weitere

eLife · 2024

DOI: 10.7554/elife.83641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Yi-Shin Chang und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Illinois at Chicago, Chicago, United States. Hauptthemen laut MEDLINE: Renal Dialysis, COVID-19, BNT162 Vaccine, COVID-19 Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

End-stage renal disease (ESRD) patients experience immune compromise characterized by complex alterations of both innate and adaptive immunity, and results in higher susceptibility to infection and lower response to vaccination. This immune compromise, coupled with greater risk of exposure to infectious disease at hemodialysis (HD) centers, underscores the need for examination of the immune response to the COVID-19 mRNA-based vaccines.

Methods

The immune response to the COVID-19 BNT162b2 mRNA vaccine was assessed in 20 HD patients and cohort-matched controls. RNA sequencing of peripheral blood mononuclear cells was performed longitudinally before and after each vaccination dose for a total of six time points per subject. Anti-spike antibody levels were quantified prior to the first vaccination dose (V1D0) and 7 d after the second dose (V2D7) using anti-spike IgG titers and antibody neutralization assays. Anti-spike IgG titers were additionally quantified 6 mo after initial vaccination. Clinical history and lab values in HD patients were obtained to identify predictors of vaccination response.

Results

Transcriptomic analyses demonstrated differing time courses of immune responses, with prolonged myeloid cell activity in HD at 1 wk after the first vaccination dose. HD also demonstrated decreased metabolic activity and decreased antigen presentation compared to controls after the second vaccination dose. Anti-spike IgG titers and neutralizing function were substantially elevated in both controls and HD at V2D7, with a small but significant reduction in titers in HD groups (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisCOVID-19BNT162 VaccineCOVID-19 VaccinesAntibodies, ViralSARS-CoV-2Kidney Failure, ChronicHumansMaleFemaleMiddle AgedAgedTranscriptomeSpike Glycoprotein, CoronavirusAntibodies, NeutralizingImmunoglobulin GmRNA VaccinesVaccination

Stichwörter der Autor:innen

COVID-19RNA sequencingbinding antibodieshemodialysishumaninfectious diseasemedicinemicrobiologyneutralizing antibodiesvaccine

Substanzen

BNT162 VaccineCOVID-19 VaccinesAntibodies, ViralSpike Glycoprotein, CoronavirusAntibodies, NeutralizingImmunoglobulin GmRNA Vaccinesspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Department of Medicine, University of Illinois at Chicago, Chicago, United States.
  • Department of Bioengineering, University of Illinois at Chicago, Chicago, United States.
  • Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, United States.
  • Department of Medicine, Stanford University, Palo Alto, United States.
  • Department of Medicine, University of Colorado Denver, Aurora, United States.
  • Department of Biological Sciences, University of Illinois at Chicago, Chicago, United States.

ORCID-Profile: Yi-Shin Chang, Kai Huang, Jessica M Lee, Christian Ascoli, Benjamin A Turturice, Patricia W Finn

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS
  • NICHD NIH HHS
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Division of Intramural Research
  • Center for Clinical and Translational Science, University of Illinois at Chicago

Zitieren

APA

Chang, Y. S., Huang, K., Lee, J. M., Vagts, C. L., Ascoli, C., Amin, M. R., Ghassemi, M., Lora, C. M., Edafetanure-Ibeh, R., Huang, Y., Cherian, R. A., Sarup, N., Warpecha, S. R., Hwang, S., Goel, R., Turturice, B. A., Schott, C., Hernandez, M., Chen, Y., …, & Perkins, D. L. (2024). Altered transcriptomic immune responses of maintenance hemodialysis patients to the COVID-19 mRNA vaccine. eLife. https://doi.org/10.7554/elife.83641

Vancouver

Chang YS, Huang K, Lee JM, Vagts CL, Ascoli C, Amin MR, et al. Altered transcriptomic immune responses of maintenance hemodialysis patients to the COVID-19 mRNA vaccine. eLife. 2024. doi:10.7554/elife.83641

BibTeX
@article{Chang2024,
  author = {Chang, Yi-Shin and Huang, Kai and Lee, Jessica M and Vagts, Christen L and Ascoli, Christian and Amin, Md-Ruhul and Ghassemi, Mahmood and Lora, Claudia M and Edafetanure-Ibeh, Russell and Huang, Yue and Cherian, Ruth A and Sarup, Nandini and Warpecha, Samantha R and Hwang, Sunghyun and Goel, Rhea and Turturice, Benjamin A and Schott, Cody and Hernandez, Montserrat and Chen, Yang and Jorgensen, Julianne and Wang, Wangfei and Rasic, Mladen and Novak, Richard M and Finn, Patricia W and Perkins, David L},
  title = {Altered transcriptomic immune responses of maintenance hemodialysis patients to the COVID-19 mRNA vaccine},
  journal = {eLife},
  year = {2024},
  doi = {10.7554/elife.83641}
}
Kostenlos starten →